| Current
Pharmaceutical Analysis
ISSN: 1573-4129



1).
Recent Advances in Solid-Phase Microextraction
and Related Techniques for Pharmaceutical and Biomedical
Analysis Pp. 65-84
Hiroyuki Kataoka, 2005, Vol: 1-1
[Abstract] |
2). Physicochemical
Profiling by Capillary Electrophoresis Pp.
41-56
Zhongjiang Jia, 2005, Vol: 1-1
[Abstract] |
3).
Critical Review of Development, Validation, and Transfer
for High Throughput Bioanalytical LC-MS/MS Methods
Pp. 3-14
Shaolian Zhou, Qi Song, Yong Tang and Weng Naidong
, 2005, Vol: 1-1
[Abstract] |
4).
Analysis of the L-Arginine/Nitric Oxide Pathway: The
Unique Role of Mass Spectrometry Pp. 15-30
Dimitrios Tsikas, 2005, Vol: 1-1
[Abstract] |
5).
Alkyl Chloroformates in Sample Derivatization Strategies
for GC Analysis Review on a Decade Use of the Reagents
as Esterifying Agents Pp. 23-43
Petr Hušek and Petr Šimek, 2006,
Vol: 2-1
[Abstract] |
6).
Multicomponent Determination of Drugs Using Flow-Injection
Analysis Pp. 127-140
Leah Hlabangana, Santiago Hernández-Cassou
and Javier Saurina, 2006, Vol: 2-2
[Abstract] |
7).
Fluorescent Chiral Derivatization Reagents Possessing
Benzofurazan Structure for the Resolution of Optical
Isomers in HPLC: The Synthesis, Characteristics and
Application Pp. 57-64
Toshimasa Toyooka, 2005, Vol: 1-1
[Abstract] |
8). Profiling Drug Membrane Transport via Immobilized
Artificial Membrane Chromatography Pp. 273
Jin Sun, Tian-Hong Zhang and Zhong-Gui He, 2005,
Vol: 1-3
[Abstract] |
9).
Electrochemical Biosensors as a Screening Tool of In
Vitro DNA Drug Interaction Pp. 217
Graziana Bagni, Mauro Ravera, Domenico Osella and
Marco Mascini, 2005, Vol: 1-3
[Abstract] |
10).
Advances in Chromatographic Analyses of Fluoroquinolones
in Pharmaceuticals and Biological Samples - A Review
Article Pp. 283
Victoria F. Samanidou, Eleni A. Christodoulou and
Ioannis N. Papadoyannis, 2005, Vol: 1-3
[Abstract] |
Abstracts

[Back
to top]
Recent Advances
in Solid-Phase Microextraction and Related Techniques for
Pharmaceutical and Biomedical Analysis
Hiroyuki Kataoka
Sample preparation is essential for isolating desired components
from complex matrices and greatly influences their reliable
and accurate analysis. Solid-phase microextraction (SPME)
is a new and effective sample preparation technique. Fibers
and capillary tubes coated with an appropriate stationary
phase are usually used for SPME, but alternative microextraction
techniques, including solid-phase dynamic extraction using
an internal coated needle, microextraction in a packed syringe
and stir-bar-sorptive extraction using a coated magnetic stir
bar, have been developed recently. These techniques, in combination
with gas chromatography (GC), GC-mass spectrometry (GC-MS),
high performance liquid chromatography (HPLC), LC-MS or capillary
electrophoresis, can be used for analysis for complex mixtures.
These microextraction techniques save preparation time, as
well as solvent purchase and disposal costs. This review summarizes
recent advances in SPME and related microextraction techniques
and their applications in pharmaceutical and biomedical analysis.
[Back to top]
Physicochemical Profiling by Capillary
Electrophoresis
Zhongjiang Jia
The physicochemical properties of pharmaceuticals such as
acid dissociation constant (pKa), octanol-water partition
coefficient (logPow), protein
binding constant, inclusion complex constant with cyclodextrin
(CD), and selfassociation are very important in drug design,
candidate selection, and drug delivery. Capillary electrophoresis
(CE) is a simple, versatile, automated, and powerful separation
technique and widely applied in physicochemical profiling
for pharmaceuticals. It has advantages over traditional potentiometric,
spectrophotometric, chromatographic, and other methods, as
CE requires very small amounts of sample and can measure compounds
with impurities and low aqueous solubility. Principles and
applications of CE in profiling various physicochemical properties
will be reviewed.
[Back to top]
Critical Review of Development, Validation,
and Transfer for High Throughput Bioanalytical LC-MS/MS Methods
Shaolian Zhou, Qi Song, Yong Tang and Weng Naidong
Swift growth in the use of LC-MS/MS for the analysis of drugs
in biological matrices has been compelled by the need for
timely and high-quality data at many stages in drug discovery
and development process: from high throughput screening of
drug candidates and rapid data generation for pre-clinical
studies to almost 'real-time' analysis of clinical samples.
Prompt and rational method development, validation, and transfer
play a pivotal role in achieving the goals of "faster,
better, and cheaper" for pharmacokinetic studies since
this could easily account for more than 50% of the time and
labor resources for a moderate-sized project. Strategy for
rational method development, validation and transfer has been
largely kept as institutional knowledge but rarely appeared
in literature. In this review article, strategies for developing
and validating robust high throughput LC-MS/MS methods will
be critically reviewed and discussed. Automated sample preparation,
fast chromatography, minimization of matrix effects, and strategy
of narrowing the gap between validation and incurred sample
analysis are just a few topics covered in this review. Other
interesting approaches for improving method efficiency and
ruggedness such as direct injection SPE and liquid/liquid
extracts as well as multiplexing of LC columns will also be
discussed. Potential pitfalls during method development and
validation are pointed out. At the end, the question "how
fast is fast enough and how fast is too fast?" will be
answered after considering all aspects of the method development
and validation.
[Back to top]
Analysis of the L-Arginine/Nitric Oxide
Pathway: The Unique Role of Mass Spectrometry
Dimitrios Tsikas
Nitric oxide (NO) is a gaseous radical molecule. In human
organism NO is produced in various cells from Larginine by
the catalytical action of NO synthases (NOS). The L-arginine/NO
pathway powerfully contributes to maintain multiple physiological
functions, including vascular tone, platelet function and
neurotransmission. The metabolic fate of NO is very complex
due to the participation of numerous compounds resulting from
the ability of NO to react practically with any biomolecule
to produce biologically active metabolites (e.g. S-nitrosothiols)
and biologically inactive metabolites (e.g. nitrate). The
concentration in biological fluids and tissues of members
of the L-arginine/NO family is of particular interest, as
it may characterize the status of this pathway in health and
disease as well as to monitor the progress of pharmacological
interventions. Thus, measurement of the NO metabolites nitrate
and nitrite is suitable to assess NO synthesis in vivo.
On the other hand, measurement of the circulating NOS inhibitor
asymmetric dimethylarginine (ADMA) was found to reliably identify
pathological conditions associated with NO-related endothelial
dysfunction. Among the various analytical methods currently
available for the analysis of the L-arginine/NO family, mass
spectrometry (MS)-based approaches such as gas chromatography-mass
spectrometry (e.g. GC-MS/MS) and liquid chromatographymass
spectrometry (e.g. LC-MS/MS) emerged indispensable analytical
tools for the reliable quantitative analysis of the whole
NO family. The present article discusses the currently available
analytical methods especially emphasizing the importance of
the MS technology to the NO field of research.
[Back to top]
Alkyl Chloroformates in Sample Derivatization
Strategies for GC Analysis Review on a Decade Use of the Reagents
as Esterifying Agents
Petr Hušek and Petr Šimek
The neccessity to derivatize polar analytes prior to separation
often disqualifies gas chromatography (GC) as a method of
choice in the field of biomedical/pharmaceutical analysis.
Laborious and lengthy protocols for treating compounds prior
to the analysis were discouraging. Only few derivatization
approaches were well-established over decades, primarily silylations.
To its assets belongs universality and efficacy, to shortcomings
necessity for dry residue and prolonged reaction time, often
under heating. Similarly, the next field-proven esterification-acylation
two-step procedures suffered from the same pre-requisites.
Current investigations in the field of derivatization turned
attention to chemical reactions proceeding in aqueous environment
and obviating multiple reaction steps and heating. Application
of alkyl chloroformates (RCF), under conditions discovered
more than a decade ago, met such criteria. Instantaneous conversion
of hydrophilic compounds to organophilic ones became often
an integral part of sample preparation procedures with neg-ligible
time and costs required. This review attempts to bring forward
some of the most important studies on RCF-mediated derivatizations
in the last decade and to figure out general utility of the
approach in analyzing polar organic compounds by GC, with
particular attention to polyfunctional organic acids, especially
amino acids (AAs).
[Back to top]
Multicomponent Determination of Drugs
Using Flow-Injection Analysis
Leah Hlabangana, Santiago Hernández-Cassou and
Javier Saurina
This paper reviews the principal strategies for multicomponent
determinations of pharmaceutical products and related compounds
using flow-injection analysis (FIA). The relevancy of this
topic in the pharmaceutical field and close areas such as
clinical, food and biochemical analysis is pointed out. As
an alternative to chromatographic and electrophoretic methods,
multicomponent FIA is specially suitable for a rapid quantification
of analytes and processing large sets of samples. The achievement
of selective measurement conditions to carry out the quantification
of each drug without interferences is commonly needed in multicomponent
analysis. The main approaches for gaining selectivity are
based on specific reagents, multi-way or fast-scanning detectors,
serial and parallel multi-channel manifolds. Alternatively,
chemometric methods for data analysis can be used when selectivity
is not fully accomplished.
[Back to top]
Fluorescent Chiral Derivatization Reagents
Possessing Benzofurazan Structure for the Resolution of Optical
Isomers in HPLC: The Synthesis, Characteristics and Application
Toshimasa Toyooka
Indirect resolution of chiral molecules, based upon pre-column
derivatization and diastereomer formation using benzofurazan
bearing chiral labeling reagents, by high-performance liquid
chromatography are described in this minireview. The synthesis,
characteristics and application of the fluorescent chiral
derivatization reagents for various functional groups, i.e.
amine (NBD-PyNCS, DBD-PyNCS, DBD-β-Pro,
DBD-hydroxyproline), carboxyl (NBD-APy, DBD-APy, ABD-APy),
carbonyl (NBD-ProCZ, DBD-ProCZ), hydroxyl (NBD-Pro-COCl, DBD-Pro-COCl)
and thiol, etc., are including in the text.
[Back to top]
Profiling Drug Membrane Transport via
Immobilized Artificial Membrane Chromatography
Jin Sun, Tian-Hong Zhang and Zhong-Gui He
The preclinical and clinical development attrition rates of
new drugs are high due to the unfavorable pharmacokinetic
properties such as poor intestinal absorption and inadequate
target tissue penetration, etc. Drug disposition
performance in nature consists of in vivo sequential
membrane transporting processes and is based on the entry
into and exit of drugs from cell, even for metabolism process
requiring drug to be delivered to the site of metabolic enzymes.
Efficient and reliable high throughput screening that predicts
these membrane permeability properties as early as possible,
in drug discovery and development program is accordingly desirable.
Immobilized artificial membrane (IAM) chromatography, one
of the biopartitioning modeling systems, covalently bonds
monolayer of phospholipid analogs onto the solid surface of
silica particles and emulates the process of drug–biomembrane
interactions in terms of rapid chromatographic method. It
is a valuably predictive model of drug membrane permeability
and biological activity. The implementation of IAM chromatography
in early drug discovery and development would effectively
lower the preclinical and clinical development attrition rates,
and would be able to increase the fraction of more drug-like
drug candidates. The interaction mechanism of drug–IAM
and its profiling in membrane transport were described in
this review.
[Back to top]
Electrochemical Biosensors as a Screening
Tool of In Vitro DNA Drug Interaction
Graziana Bagni, Mauro Ravera, Domenico Osella and Marco
Mascini
The interaction of some antitumoural drugs with double stranded
DNA immobilised on screen-printed electrodes was studied as
a screening tool for in vitro DNA-drug interaction.
In this case DNA biosensors are used for qualitative analysis
as a rapid indication of the behaviour of DNA with different
metal complexes and are proposed as an alternative method
of the most common techniques. In fact, DNA based electrochemical
biosensors represent a new research field with interesting
possibilities for practical application in various areas such
as environmental and pharmaceutical screening. Interactions
of DNA with chemicals can result in various types of DNA damage.
Many small molecules show a high affinity for DNA and they
can interact with the nucleic acids immobilised on the electrode
surface. The interactions between DNA and drugs can cause
chemical and conformational modifications of nucleic acids
and thus variation of the electrochemical properties of DNA.
The presence of compounds with affinity for DNA is measured
by their effect on the guanine or adenine oxidation peak.
A great advantage of this kind of biosensors is that they
are cost effective and they can be used with a small portable
potentiostat with disposable screen-printed electrodes (SPE).
In this work, screening of some antitumoural drug is reported
as example of in vitro interaction. Preliminary results
have been obtained analysing different type of DNA-interacting
agents as metal (Pt, Ru and Ti) complexes. The drugs analysed
were cis-diaminedichloroplatinum(II) cis-[Pt(Cl)2(NH3)2]
(cisplatin); diamine(1,1-cyclobutanedicarboxylate)platinum(II)
[Pt(NH3)2C4H6C2O4]
(carboplatinum);cis-diamineplatinum(II)malonate cis-[Pt(NH3)2
C3H2O4]
(cis-malonate); platinum(bipyridile(pyridine)2)2+
[Pt(bpy)(py)2]2+;
titanocene dichloride [(η5-C5H5)2TiCl2]
(titanocene); titanocenebisglycine [(η5-C5H5)2Ti(gly)2]
and imidazolium trans-imidazoledimethylsulfoxidetetrachloro-ruthenate
[Ru(III)Cl4(DMSO)(Im)][ImH]
(NAMI-A). Groove binding, electrostatic interactions, hydrogen
and/or van der Waals bonds and intercalation of planar condensed
aromatic ring systems between adjacent base pairs are the
interactions that the DNA electrochemical biosensor can detect.
Different response behaviour has been observed with these
drugs according to different interaction with DNA.
[Back to top]
Advances in Chromatographic Analyses
of Fluoroquinolones in Pharmaceuticals and Biological Samples
- A Review Article
Victoria F. Samanidou, Eleni A. Christodoulou and Ioannis
N. Papadoyannis
Fluoroquinolones constitute a member of quinolone antibiotics,
an expanding group of synthetic antibiotics, which are effective
towards pathogens resistant to other antibacterials. They
are broadly used for the treatment of several infections,
both in human and veterinary medicine, due to their favourable
kinetics and broad antibacterial activity.
Herein recent advances in chromatographic methods for determination
of fluoroquinolones and their metabolites are reviewed, focusing
on sample pretreatment, chromatographic conditions, detection
techniques, method validation and application to real samples.
Results of published methods are comparatively presented and
criticized.
|